XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.3
Collaboration and license agreements - Schedule of revenue from collaboration agreements (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Revenue from collaboration agreements $ 15,362 $ 11,072 $ 30,407 $ 17,495
MKDG Agreement        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Revenue from collaboration agreements 2,368 0 4,317 0
Merck Agreement        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Revenue from collaboration agreements 1,684 0 3,431 0
Roche Agreement        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Revenue from collaboration agreements 414 8,223 2,865 8,736
Biogen Agreement        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Revenue from collaboration agreements 8,000 2,849 16,898 7,689
Calico Agreement        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Revenue from collaboration agreements $ 0 $ 0 $ 0 $ 1,070